@article{923a7619c6584a0dadeff3cc9ba1f09d,
title = "Real-world outcomes with immuno-oncology therapies in advanced melanoma: Final results of the OPTIMIzE registry study",
keywords = "advanced melanoma, adverse events, immuno-oncology, overall survival, quality of life, real-world",
author = "Kirkwood, \{John M\} and Kottschade, \{Lisa A\} and McWilliams, \{Robert R\} and Khushalani, \{Nikhil I\} and Sekwon Jang and Sigrun Hallmeyer and McDermott, \{David F\} and Hussein Tawbi and Min Che and Cho-Han Lee and Corey Ritchings and Le, \{Trong Kim\} and Boas Park and Scott Ramsey and \{Advocate Hematology/Oncology Faculty - Lutheran General\}",
note = "Kirkwood JM, Kottschade LA, McWilliams RR, et al. Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study. Immunotherapy. 2024;16(1):29-42. doi:10.2217/imt-2022-0292",
year = "2024",
month = jan,
day = "1",
doi = "10.2217/imt-2022-0292",
language = "American English",
volume = "16",
pages = "29--42",
journal = "Immunotherapy",
number = "1",
}